TOMM20 and acute myeloid leukemia: Importantly, rosuvastatin pretreatment in TP53mut MOLM14 AML cells completely abrogated the AraC-induced increase in TOMM20 while significantly increasing mitochondrial ROS to the same degree as M14-WT1 (Fig. 4B, C).